Company Filing History:
Years Active: 2016
Title: Oliver Renner - Innovator in Cancer Treatment
Introduction
Oliver Renner is a notable inventor based in Spain, recognized for his contributions to the field of cancer treatment. His work primarily focuses on the development of innovative compounds that serve as potential therapeutic agents.
Latest Patents
Oliver Renner has developed a patent related to Tricyclic Inhibitors of ATR. This patent includes compounds that are inhibitors of ATR and are potentially useful in treating cancer. The patent also covers pharmaceutical compositions of these chemical entities, combination products, and methods of treatment using these compositions.
Career Highlights
Throughout his career, Oliver Renner has made significant strides in the pharmaceutical field. His research has contributed to the understanding of cancer treatment and the development of new therapeutic options.
Collaborations
Oliver has collaborated with esteemed colleagues, including Joaquin Pastor Fernandez and Oscar Fernandez-Capetillo Ruiz. These collaborations have enhanced the scope and impact of his research.
Conclusion
Oliver Renner's innovative work in developing Tricyclic Inhibitors of ATR showcases his commitment to advancing cancer treatment. His contributions, along with his collaborations, highlight the importance of teamwork in scientific research.